British drug giant walking a tightrope between ‘incredible’ Chinese pharma market and US’s tough line
British drug giant walking a tightrope between ‘incredible’ Chinese pharma market and US’s tough line
Copy link
Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the Atlantic
Pascal Soriot declares his ‘love’ for US amid fears his pharma giant could quit the FTSE
"We are working with the government and trying to find constructive solutions so that Americans pay less for their medicines."
The head of the pharmaceutical giant warns that Europe's decline in manufacturing innovative medicines is likely to accelerate as…
AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly…
